Advisory: Give yourself extra time when travelling by car to Toronto General Hospital, Princess Margaret Cancer Centre, or Toronto Rehab University Centre. City of Toronto construction on University Ave. may cause delays.
At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians,
staff, services and resources into 10 medical programs to meet the needs of our patients and help us make
the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in
Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international
source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community
and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one
of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases,
podcasts and more.
A recent study led by Dr. Connie Marras, clinician-scientist at the Krembil Research Institute at UHN, and Dr. Priti Gros, clinical fellow at Toronto Western Hospital, suggests that certain drugs used to treat prostate conditions may help to reduce men's risk of Parkinson's disease.
The researchers examined data from various provincial and federal databases to identify adult males who were prescribed drugs to treat prostate enlargement, a noncancerous condition that interferes with urination.
Between 1997 and 2019, 265,745 males in Ontario filled prescriptions for at least one of four drugs commonly used to treat prostate enlargement: terazosin, doxazosin, alfuzosin and tamsulosin. The first three of these drugs are known as phosphoglycerate kinase 1 (PGK1) activators, a class of drugs that improve the way cells manage energy.
"Previous research suggests that PGK1 activators have protective effects on the brain in experimental models of Parkinson's disease," explains Dr. Marras. "This may be because they improve the way that cells manage energy, and Parkinson's disease is associated with impaired energy management in brain cells.
"We wanted to know if continued use of these drugs is associated with fewer new cases of Parkinson's disease in the adult male population," Dr. Marras adds. "We also wanted to see if the effects of these drugs differ from that of tamsulosin, a non-PGK1 activator."
The researchers found that sustained use of all four drugs was associated with a lower risk of developing Parkinson's disease in men over the age of 66. PGK1 activators were associated with a six per cent reduction in disease incidence per year of use, and tamsulosin was associated with an eight per cent reduction per year of use.
"We found that regular use of PGK1 activators, as well as tamsulosin, was associated with reductions in the incidence of Parkinson's disease," says Dr. Marras.
"Further clinical studies are needed to determine how each of these drugs reduces an individual's risk for developing Parkinson's disease, and whether they may also be useful for treating the disease after it has developed."
This work was supported by ICES, the Bresler Family Research Fund and UHN Foundation.
Read more about the study.